Thromplat 25mg Tablet

About

Thromplat 25mg Tablet contains clopidogrel, an antiplatelet medication that functions by irreversibly inhibiting the P2Y12 ADP receptor on platelets. This action prevents platelet activation and aggregation, which are critical steps in thrombus formation. As a prodrug, clopidogrel requires metabolic conversion by hepatic cytochrome P450 enzymes, primarily CYP2C19, into its active metabolite. This lower dose formulation is typically used in specific clinical scenarios where a reduced antiplatelet effect is desired or in patients who may be more susceptible to bleeding, while still aiming to prevent serious cardiovascular events like myocardial infarction and stroke. It provides a tailored approach to antiplatelet therapy, balancing efficacy with safety in vulnerable populations.

Uses

• Prevention of atherothrombotic events in specific patient populations.
• Adjunctive therapy in certain acute coronary syndrome cases.
• Long-term management after stent placement (off-label for this dose).
• For patients requiring a lower antiplatelet dose.

Directions For Use

Take orally, usually once daily, with or without food. Do not crush or chew.

Benefits

• Reduces risk of thrombotic events.
• Lower dose for specific patient needs.
• Prevents platelet aggregation.
• Oral and convenient administration.
• Part of established cardiovascular regimens.
• May be suitable for patients with higher bleeding risk.

Side Effects

• Bleeding (e.g., bruising, epistaxis).
• Gastrointestinal discomfort.
• Diarrhea.
• Dyspepsia.
• Skin rash.
• Headache.
• Dizziness.
• Nausea.
• Abdominal pain.
• Pruritus.
• Thrombotic thrombocytopenic purpura (TTP) (very rare).
• Neutropenia (very rare).

Safety Measures

• Alcohol - Limit alcohol intake, as it can increase the risk of gastrointestinal bleeding when used concurrently with antiplatelet medications.
• Pregnancy - Use only if the potential benefit justifies the potential risk to the fetus. Limited human data available. Consult a healthcare provider.
• Breastfeeding - Not recommended. It is unknown if clopidogrel or its metabolites are excreted in human milk. Discontinue breastfeeding during treatment.
• Liver - Use with caution in patients with severe hepatic impairment due to the drug's metabolism in the liver.
• Kidney - Use with caution in patients with renal impairment. No dose adjustment is generally required, but close monitoring is prudent.
• Lung - No specific contraindications or precautions related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.